首頁 > 市場調查報告書 > 製藥

骨疾病

市場調查報告書

商品編碼

1461288

跟骨骨骺炎治療市場，依疾病類型、依藥物、依應用、依給藥途徑、依配銷通路、依地理位置

Severs Disease Treatment Market, By Disease Type, By Drug, By Application, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2024年03月08日 | 出版商:

Coherent Market Insights | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2024 年全球跟骨骨骺炎治療市場價值為 13.4 億美元，預計到 2031 年將達到 18.7 億美元，2024 年至 2031 年年複合成長率(CAGR) 為 4.9%。

報告範圍		報告詳情
基準年：	2023年	2023/2024 年市場規模：	13.4 億美元
歷史數據：	2019年至2023年	預測期：	2024年至2031年
預測期間 2023/2024 至 2030/2031 年複合成長率：	4.90%	2030/2031 價值預測：	18.7 億美元

各種疾病治療市佔率 (%)，依地區，2024 年

塞弗氏症，也稱為跟骨骨骺炎，是活躍兒童足跟疼痛的常見原因。這是由於孩子進行跑步和跳躍等高衝擊力活動時，跟骨（跟骨）的生長板受到壓力和損傷而引起的。由於生長板尚未完全形成，這會反覆拉動生長板，從而導致發炎和疼痛。它通常影響 8 至 14 歲的兒童，因為他們的腳跟骨正在快速生長。跟骨過度生長暫時超過了生長板韌帶的強度，從而引起症狀。治療的目的是在生長板完全形成時減少活動並緩解症狀。

市場動態：

全球塞弗氏症治療市場的推動因素是兒童參與體育活動的增加以及家長對足部和腳踝疾病的認知不斷提高。此外，不斷發展的醫療基礎設施和越來越多的醫療診斷和治療選擇也推動了市場的成長。但塞弗氏症常被誤診為跟腱炎或足底筋膜炎，一定程度上抑制了市場。此外，物理治療等替代疼痛管理療法也構成了課題。關鍵機會包括制定先進的治療方案、利用遠距醫療以及針對滲透率不足的地區。

研究的主要特點：

該報告深入分析了全球塞弗氏症治療市場，並提供了預測期（2024-2031）的市場規模（十億美元）和年複合成長率（CAGR%），以2023年為基準年。
它闡明了不同區隔市場的潛在收入成長機會，並解釋了該市場有吸引力的投資主張矩陣。
這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
它根據以下參數（例如公司亮點、產品組合、主要亮點、財務表現和策略）介紹了全球塞弗氏症治療市場的主要參與者。
本研究涵蓋的主要公司包括阿斯特捷利康、Horizon Therapeutics plc、賽諾菲、諾華公司、Sun Pharmaceutical Industries Ltd.、Cipla Inc.、LEO Pharma A/S、AbbVie Inc.、Mylan NV、Teva Pharmaceutical Industries Ltd.。
該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球塞弗疾病治療市場報告迎合了該行業的各個利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和金融分析師。
利害關係人可以透過用於分析全球塞弗氏症治療市場的各種策略矩陣輕鬆做出決策。

AstraZeneca
- 公司簡介
- 產品/服務組合
- 財務績效
- 最新動態/更新
- 戰略概覽
Horizon Therapeutics plc
Sanofi
Novartis AG
Sun Pharmaceutical Industries Ltd.
Cipla Inc.
LEO Pharma A/S
AbbVie Inc.
Mylan NV
Teva Pharmaceutical Industries Ltd.
Aurobindo Pharma
Lonza
Lupin
Dr. Reddy's Laboratories Ltd.
IBSA Institut Biochimique SA

第 11 章：參考文獻與研究方法

參考
研究方法論

簡介目錄

Product Code: CMI6737

The global Sever's Disease Treatment Market is estimated to be valued at USD 1.34 Bn in 2024 and is expected to reach USD 1.87 Bn by 2031, growing at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 1.34 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	4.90%	2030/2031 Value Projection:	US$ 1.87 Bn

Severs Disease Treatment Market Share (%), By Region, 2024

Sever's disease, also known as calcaneal apophysitis, is a common cause of heel pain in active children. It is caused by the growth plate of the heel bone (calcaneus) being stressed and injured as the child engages in high-impact activities like running and jumping. As the growth plate is not yet fully formed, this repetitively pulls on the growth plate which leads to inflammation and pain. It typically affects children between ages 8-14, as their heel bones are growing rapidly. The excessive heel bone growth temporarily outstrips the strength of the growth plate ligaments causing symptoms. Treatment aims to reduce activity and relieve symptoms while the growth plate fully forms.

Market Dynamics:

The global Sever's disease treatment market is driven by the rising participation of children in sports activities and growing awareness among parents regarding foot and ankle conditions. Moreover, the developing healthcare infrastructure and increasing access to medical diagnosis and treatment options is also fueling the market growth. However, frequent misdiagnosis of Sever's disease as Achilles tendinitis or plantar fasciitis restraints the market to some extent. Furthermore, alternative pain management therapies like physiotherapy pose a challenge. Key opportunities include development of advanced treatment protocols, leveraging telemedicine, and targeting underpenetrated regions.

Key Features of the Study:

This report provides an in-depth analysis of the global Sever's disease treatment market, and provides market size (USD Bn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global Sever's disease treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
The key companies covered as a part of this study include AstraZeneca, Horizon Therapeutics plc, Sanofi, Novartis AG, Sun Pharmaceutical Industries Ltd., Cipla Inc., LEO Pharma A/S, AbbVie Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Lonza, Lupin, Dr. Reddy's Laboratories Ltd., and IBSA Institut Biochimique SA.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global Sever's disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Sever's disease treatment market.

Detailed Segmentation:

Disease Type:
- Acute
- Chronic
Drug:
- Diclofenac
- Etodolac
- Indomethacin
- Celecoxib
- Others
Type:
- Over-the-counter
- Prescription
Route of Administration:
- Oral
- Parenteral
- Others (Topical, etc.)
Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- AstraZeneca
- Horizon Therapeutics plc
- Sanofi
- Novartis AG
- Sun Pharmaceutical Industries Ltd.
- Cipla Inc.
- LEO Pharma A/S
- AbbVie Inc.
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Aurobindo Pharma
- Lonza
- Lupin
- Reddy's Laboratories Ltd.
- IBSA Institut Biochimique SA

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Disease Type
- Market Snapshot, By Drug
- Market Snapshot, By Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Market Scenario - Conservative, Likely, Opportunistic
Market Opportunity Map

3. Key Insights

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancements
Merger, Acquisition and Collaboration Scenario
Recent Product Approvals
Company Market Share Analysis
Identification of Key Players in each Region
Regulatory Scenario
Pricing Analysis

4. Global Sever's Disease Treatment Market, By Disease Type, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Acute, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Chronic, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

5. Global Sever's Disease Treatment Market, By Drug, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Diclofenac, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Etodolac, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Indomethacin, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Celecoxib, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others (Naproxen, etc.) , 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

6. Global Sever's Disease Treatment Market, By Type, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Over-the-counter, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Prescription, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

7. Global Sever's Disease Treatment Market, By Route of Administration, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Oral, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Parenteral, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others (Topical, etc.), 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

8. Global Sever's Disease Treatment Market, By Distribution Channel, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Hospital Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Retail Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Online Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

9. Global Sever's Disease Treatment Market, By Region, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Billion)
- Market Y-o-Y Growth Comparison (%), 2020 - 2031, (US$ Billion)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Disease Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Drug, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, By Disease Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Drug, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Disease Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Drug, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
China
India
Japan
Australia
South Korea
ASEAN
Rest Of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Disease Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Drug, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Middle East
Middle East
- Introduction
- Market Size and Forecast, By Disease Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Drug, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
GCC
Israel
Rest of the Middle East
Africa
- Introduction
- Market Size and Forecast, By Disease Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Drug, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (US$ Billion)
South Africa
North Africa
Central Africa

10. Company Profiles - Global Sever's Disease Treatment Market

AstraZeneca
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
Horizon Therapeutics plc
Sanofi
Novartis AG
Sun Pharmaceutical Industries Ltd.
Cipla Inc.
LEO Pharma A/S
AbbVie Inc.
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Aurobindo Pharma
Lonza
Lupin
Dr. Reddy's Laboratories Ltd.
IBSA Institut Biochimique SA